Redeye is now more cautious on the very near-term outlook, despite Q4 sales at a new ATH. Gross margins are currently under some pressure and will remain so, we believe, until OXE Marine’s price adjustments feed through in H2’24. On a positive note, recent deliveries to Government clients have reinforced the OXE brand, improving their chances for future business.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/